ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 242 filers reported holding ICU MED INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $449,825 | -9.4% | 3,788 | -18.1% | 0.00% | -33.3% |
| Q1 2024 | $496,248 | -77.9% | 4,624 | -79.5% | 0.00% | -76.9% |
| Q4 2023 | $2,247,541 | +296.3% | 22,534 | +372.9% | 0.01% | +333.3% |
| Q3 2023 | $567,083 | -84.7% | 4,765 | -77.2% | 0.00% | -87.0% |
| Q2 2023 | $3,717,043 | -12.0% | 20,860 | -18.5% | 0.02% | -11.5% |
| Q1 2023 | $4,222,316 | +11.8% | 25,596 | +6.8% | 0.03% | +23.8% |
| Q4 2022 | $3,775,268 | -20.3% | 23,973 | -23.8% | 0.02% | -12.5% |
| Q3 2022 | $4,739,000 | -34.2% | 31,466 | -2.8% | 0.02% | -17.2% |
| Q1 2022 | $7,207,000 | +37.5% | 32,369 | +46.6% | 0.03% | -3.3% |
| Q4 2021 | $5,242,000 | +14.7% | 22,087 | +12.7% | 0.03% | +20.0% |
| Q3 2021 | $4,572,000 | +4.2% | 19,591 | -8.1% | 0.02% | -10.7% |
| Q2 2021 | $4,386,000 | – | 21,312 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
| CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
| PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
| Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
| GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
| Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
| Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
| PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
| DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
| GAM Holding AG | 90,452 | $20,769,000 | 1.05% |